Concert Health, a leading behavioral health medical group, today announced a collaboration with Mass General Brigham, an integrated academic health care system, to expand behavioral health services delivered through primary care.
The launch program will be rolled out in Mass General Brigham’s primary care facilities throughout Massachusetts, giving more than 400 primary care providers and their patients access to Concert Health’s behavioral health services.Collaborative care is an evidence-based approach to identifying and treating patients with behavioral health conditions such as anxiety and depression in primary care settings.
Concert Health was created to facilitate the integration of comprehensive behavioral health services into primary care on a large scale. Its distinctive approach and technology platform simplify the process for major healthcare systems and medical groups to incorporate its services into their overall care offerings. With an impressive team of nearly 200 highly skilled clinicians, Concert Health provides both patients and healthcare providers with remote access to behavioral health professionals, including psychiatrists and care managers. This access is available through primary care providers, pediatricians, and OB/GYNs within 24-48 hours. To date, Concert Health has provided care for over 70,000 patients, with 55% of them covered by Medicaid and Medicare.
What You Should Know: Medical imaging technology company Medmo announced a $9 million funding round led by Lerer Hippeau,alongside existing investors Jerusalem Venture Partners (JVP), C2 Ventures and Stone IsraVentures. In
There have been some exciting developments in the psychedelic world, continuing the trend from weeks prior. The biggest story is that Australia became the first
Mass General Brigham, Concert Health Collaborate to Expand Behavioral Health Services for Primary Care
by Syed Hamza Sohail Leave a Comment
What You Should Know:
Medmo Secures $9M to Streamline Medical Imaging
What You Should Know: Medical imaging technology company Medmo announced a $9 million funding round led by Lerer Hippeau,alongside existing investors Jerusalem Venture Partners (JVP), C2 Ventures and Stone IsraVentures. In
The Biggest Psychedelic News Stories of the Week – July 7 | Psychedelic Spotlight
There have been some exciting developments in the psychedelic world, continuing the trend from weeks prior. The biggest story is that Australia became the first
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16% – Biotech Investments
Medartis Holding AG / Key word(s): Annual Results 12-March-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer